CSL ups recruitment efforts as labor crunch hits biotechs

CSL ups recruitment efforts as labor crunch hits biotechs

Biotech giants CSL and Ansell say finding workers is an increasing challenge in a tight post-COVID labour market.

  • byEmma Koehn

Latest

Three numbers that highlight reporting season this week

Three numbers that highlight reporting season this week

Bunnings went into reverse,CSL got a flu vaccine booster,and all eyes were on Fortescue’s shock dividend payment this week.

  • byColin Kruger
‘Be prepared’ for flu,warns CSL boss after record vaccine demand

‘Be prepared’ for flu,warns CSL boss after record vaccine demand

Australia’s home-grown biotech giant saw half-year net profits drop as constraints on plasma collection start to impact its revenues.

  • byEmma Koehn
CSL doubles down on Mexican border ban fight

CSL doubles down on Mexican border ban fight

The biotech giant and its peers argue that blocking plasma donors at the US border will hurt the industry in the longer term.

  • byEmma Koehn
Dangerous liaisons:CSL’s other line of work is poisonous

Dangerous liaisons:CSL’s other line of work is poisonous

Biotech giant CSL makes countless life-saving therapies,but there’s one medicine it hopes gets thrown out before it ever has to be used.

  • byEmma Koehn
‘A problem with women’:CSL hit with gender discrimination claim

‘A problem with women’:CSL hit with gender discrimination claim

The case has also lifted the lid on the blood giant’s dealings with the Trump administration,including allegations campaign contributions were directed to further the political aspirations of the claimant’s direct boss.

  • bySarah Danckert
Advertisement
Inquiry hears how a Sydney schoolboy was given blood from a heroin addict
Exclusive
Illness

Inquiry hears how a Sydney schoolboy was given blood from a heroin addict

As an ill child Charles MacKenzie was walled off from the world to keep him safe - until blood from a former prison inmate was pumped into his veins.

  • byCarrie Fellner
‘Perfect sense’:CSL looks to future with mammoth diversification play

‘Perfect sense’:CSL looks to future with mammoth diversification play

The Australian biotech giant will tap investors for billions of dollars to help fund the biggest takeover in its history.

  • byEmma Koehn
CSL shares slide on takeover talks

CSL shares slide on takeover talks

The biotech giant admitted it was in takeover talks Swiss pharma firm Vifor.

  • byEmma Koehn
CSL to appeal after losing challenge to Mexican donor ban

CSL to appeal after losing challenge to Mexican donor ban

The biotech giant has lost its bid to overturn recent rules blocking Mexicans from entering its US plasma centres.

  • byEmma Koehn
Swiss pharma deal could boost CSL’s kidney treatment products

Swiss pharma deal could boost CSL’s kidney treatment products

Vifor Pharma is looking to expand its global reach for iron deficiency products and has a strong position in Australia.

  • byEmma Koehn